rs545511851
Positions:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PP2BS2
The NM_000719.7(CACNA1C):c.2437G>A(p.Gly813Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000159 in 1,570,584 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000015 ( 0 hom. )
Consequence
CACNA1C
NM_000719.7 missense
NM_000719.7 missense
Scores
7
7
3
Clinical Significance
Conservation
PhyloP100: 7.77
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), CACNA1C. . Gene score misZ 6.4654 (greater than the threshold 3.09). Trascript score misZ 7.2674 (greater than threshold 3.09). GenCC has associacion of gene with intellectual disability, neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures, Brugada syndrome, long QT syndrome, short QT syndrome, long qt syndrome 8, Timothy syndrome, Brugada syndrome 3.
BS2
High AC in GnomAdExome4 at 21 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1C | NM_000719.7 | c.2437G>A | p.Gly813Arg | missense_variant | 17/47 | ENST00000399655.6 | NP_000710.5 | |
CACNA1C | NM_001167623.2 | c.2437G>A | p.Gly813Arg | missense_variant | 17/47 | ENST00000399603.6 | NP_001161095.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1C | ENST00000399603.6 | c.2437G>A | p.Gly813Arg | missense_variant | 17/47 | 5 | NM_001167623.2 | ENSP00000382512.1 | ||
CACNA1C | ENST00000399655.6 | c.2437G>A | p.Gly813Arg | missense_variant | 17/47 | 1 | NM_000719.7 | ENSP00000382563.1 | ||
CACNA1C | ENST00000682544.1 | c.2527G>A | p.Gly843Arg | missense_variant | 17/50 | ENSP00000507184.1 | ||||
CACNA1C | ENST00000406454.8 | c.2437G>A | p.Gly813Arg | missense_variant | 17/48 | 5 | ENSP00000385896.3 | |||
CACNA1C | ENST00000399634.6 | c.2437G>A | p.Gly813Arg | missense_variant | 17/47 | 5 | ENSP00000382542.2 | |||
CACNA1C | ENST00000683824.1 | c.2602G>A | p.Gly868Arg | missense_variant | 18/48 | ENSP00000507867.1 | ||||
CACNA1C | ENST00000347598.9 | c.2437G>A | p.Gly813Arg | missense_variant | 17/49 | 1 | ENSP00000266376.6 | |||
CACNA1C | ENST00000344100.7 | c.2437G>A | p.Gly813Arg | missense_variant | 17/47 | 1 | ENSP00000341092.3 | |||
CACNA1C | ENST00000327702.12 | c.2437G>A | p.Gly813Arg | missense_variant | 17/48 | 1 | ENSP00000329877.7 | |||
CACNA1C | ENST00000399617.6 | c.2437G>A | p.Gly813Arg | missense_variant | 17/48 | 5 | ENSP00000382526.1 | |||
CACNA1C | ENST00000682462.1 | c.2527G>A | p.Gly843Arg | missense_variant | 17/47 | ENSP00000507105.1 | ||||
CACNA1C | ENST00000683781.1 | c.2527G>A | p.Gly843Arg | missense_variant | 17/47 | ENSP00000507434.1 | ||||
CACNA1C | ENST00000683840.1 | c.2527G>A | p.Gly843Arg | missense_variant | 17/47 | ENSP00000507612.1 | ||||
CACNA1C | ENST00000683956.1 | c.2527G>A | p.Gly843Arg | missense_variant | 17/47 | ENSP00000506882.1 | ||||
CACNA1C | ENST00000399638.5 | c.2437G>A | p.Gly813Arg | missense_variant | 17/48 | 1 | ENSP00000382547.1 | |||
CACNA1C | ENST00000335762.10 | c.2512G>A | p.Gly838Arg | missense_variant | 18/48 | 5 | ENSP00000336982.5 | |||
CACNA1C | ENST00000399606.5 | c.2437G>A | p.Gly813Arg | missense_variant | 17/48 | 1 | ENSP00000382515.1 | |||
CACNA1C | ENST00000399621.5 | c.2437G>A | p.Gly813Arg | missense_variant | 17/47 | 1 | ENSP00000382530.1 | |||
CACNA1C | ENST00000399637.5 | c.2437G>A | p.Gly813Arg | missense_variant | 17/47 | 1 | ENSP00000382546.1 | |||
CACNA1C | ENST00000402845.7 | c.2437G>A | p.Gly813Arg | missense_variant | 17/47 | 1 | ENSP00000385724.3 | |||
CACNA1C | ENST00000399629.5 | c.2437G>A | p.Gly813Arg | missense_variant | 17/47 | 1 | ENSP00000382537.1 | |||
CACNA1C | ENST00000682336.1 | c.2512G>A | p.Gly838Arg | missense_variant | 18/47 | ENSP00000507898.1 | ||||
CACNA1C | ENST00000399591.5 | c.2437G>A | p.Gly813Arg | missense_variant | 17/46 | 1 | ENSP00000382500.1 | |||
CACNA1C | ENST00000399595.5 | c.2437G>A | p.Gly813Arg | missense_variant | 17/46 | 1 | ENSP00000382504.1 | |||
CACNA1C | ENST00000399649.5 | c.2437G>A | p.Gly813Arg | missense_variant | 17/46 | 1 | ENSP00000382557.1 | |||
CACNA1C | ENST00000399597.5 | c.2437G>A | p.Gly813Arg | missense_variant | 17/47 | 1 | ENSP00000382506.1 | |||
CACNA1C | ENST00000399601.5 | c.2437G>A | p.Gly813Arg | missense_variant | 17/47 | 1 | ENSP00000382510.1 | |||
CACNA1C | ENST00000399641.6 | c.2437G>A | p.Gly813Arg | missense_variant | 17/47 | 1 | ENSP00000382549.1 | |||
CACNA1C | ENST00000399644.5 | c.2437G>A | p.Gly813Arg | missense_variant | 17/47 | 1 | ENSP00000382552.1 | |||
CACNA1C | ENST00000682835.1 | c.2437G>A | p.Gly813Arg | missense_variant | 17/47 | ENSP00000507282.1 | ||||
CACNA1C | ENST00000683482.1 | c.2428G>A | p.Gly810Arg | missense_variant | 17/47 | ENSP00000507169.1 | ||||
CACNA1C | ENST00000682686.1 | c.2437G>A | p.Gly813Arg | missense_variant | 17/46 | ENSP00000507309.1 | ||||
CACNA1C | ENST00000480911.6 | n.*1044G>A | non_coding_transcript_exon_variant | 15/27 | 5 | ENSP00000437936.2 | ||||
CACNA1C | ENST00000480911.6 | n.*1044G>A | 3_prime_UTR_variant | 15/27 | 5 | ENSP00000437936.2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152186Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
4
AN:
152186
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000336 AC: 6AN: 178656Hom.: 0 AF XY: 0.0000314 AC XY: 3AN XY: 95640
GnomAD3 exomes
AF:
AC:
6
AN:
178656
Hom.:
AF XY:
AC XY:
3
AN XY:
95640
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000148 AC: 21AN: 1418280Hom.: 0 Cov.: 31 AF XY: 0.00000855 AC XY: 6AN XY: 701608
GnomAD4 exome
AF:
AC:
21
AN:
1418280
Hom.:
Cov.:
31
AF XY:
AC XY:
6
AN XY:
701608
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152304Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74478
GnomAD4 genome
AF:
AC:
4
AN:
152304
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
74478
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
2
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:6Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:4
Uncertain significance, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 18, 2022 | Reported in association with LQTS in published literature (Marschall et al., 2019); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 31737537) - |
Uncertain significance, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Timothy syndrome;C2678478:Brugada syndrome 3;CN260585:Long qt syndrome 8 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Aug 10, 2021 | - - |
Timothy syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center For Human Genetics And Laboratory Diagnostics, Dr. Klein, Dr. Rost And Colleagues | May 08, 2018 | - - |
Long QT syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 13, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.;.;.;T;.
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Uncertain
.;M;.;M;M;M;M;M;M;M;M;M;M;M;M;M;.;M;M;M;.;.;.
PrimateAI
Pathogenic
T
PROVEAN
Uncertain
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
REVEL
Uncertain
Sift
Uncertain
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
Sift4G
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
Polyphen
1.0, 0.024, 1.0, 0.90, 1.0, 0.22
.;D;D;B;D;P;D;D;D;B;D;D;D;D;D;D;.;D;D;.;D;.;D
Vest4
MutPred
0.31
.;Gain of catalytic residue at P816 (P = 5e-04);Gain of catalytic residue at P816 (P = 5e-04);Gain of catalytic residue at P816 (P = 5e-04);Gain of catalytic residue at P816 (P = 5e-04);Gain of catalytic residue at P816 (P = 5e-04);Gain of catalytic residue at P816 (P = 5e-04);Gain of catalytic residue at P816 (P = 5e-04);Gain of catalytic residue at P816 (P = 5e-04);Gain of catalytic residue at P816 (P = 5e-04);Gain of catalytic residue at P816 (P = 5e-04);Gain of catalytic residue at P816 (P = 5e-04);Gain of catalytic residue at P816 (P = 5e-04);Gain of catalytic residue at P816 (P = 5e-04);Gain of catalytic residue at P816 (P = 5e-04);Gain of catalytic residue at P816 (P = 5e-04);Gain of catalytic residue at P816 (P = 5e-04);Gain of catalytic residue at P816 (P = 5e-04);Gain of catalytic residue at P816 (P = 5e-04);Gain of catalytic residue at P816 (P = 5e-04);Gain of catalytic residue at P816 (P = 5e-04);Gain of catalytic residue at P816 (P = 5e-04);Gain of catalytic residue at P816 (P = 5e-04);
MVP
MPC
2.2
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at